Systematic study of ophthalmological findings in 10 patients with PEX1-mediated Zellweger spectrum disorder

References

• Shimozawa N, Nagase T, Takemoto Y, Ohura T, Suzuki Y, Kondo N. Genetic heterogeneity of peroxisome biogenesis disorders among Japanese patients: evidence for a founder haplotype for the most common PEX10 gene mutation. American J Med Genet. 2003;120A:40–3. doi:10.1002/ajmg.a.20030.
   PubMed Web of Science ®Google Scholar
• Levesque S, Morin C, Guay S-P, Villeneuve J, Marquis P, Yik WY, Jiralerspong S, Bouchard L, Steinberg S, Hacia JG, et al. A founder mutation in the PEX6 gene is responsible for increased incidence of Zellweger syndrome in a French Canadian population. BMC Med Genet. 2012;13(1):72–72. doi:10.1186/1471-2350-13-72.
   PubMedGoogle Scholar
• Scriver CR, Childs B. The metabolic & molecular bases of inherited disease. 8th/assoc. : Barton Childs … [et al.] edn. New York [etc.]: McGraw-Hill, Medical Publishing Division; 2001.
   Google Scholar
• Klouwer FC, Huffnagel I, Ferdinandusse S, Waterham H, Wanders R, Engelen M, Poll-The B. Clinical and biochemical pitfalls in the diagnosis of peroxisomal disorders. Neuropediatrics. 2016;47:205–20. doi:10.1055/s-0036-1582140.
   PubMed Web of Science ®Google Scholar
• Waterham HR, Ebberink MS. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta. 2012;1822(9):1430–41. doi:10.1016/j.bbadis.2012.04.006.
   PubMed Web of Science ®Google Scholar
• Waterham HR, Ferdinandusse S, Wanders RJA. Human disorders of peroxisome metabolism and biogenesis. Biochimica et Biophysica Acta (BBA) - Mol Cell Res. 2016;1863:922–33. doi:10.1016/j.bbamcr.2015.11.015.
   PubMed Web of Science ®Google Scholar
• Fujiki Y, Okumoto K, Honsho M, Abe Y. Molecular insights into peroxisome homeostasis and peroxisome biogenesis disorders. Biochimica et Biophysica Acta (BBA) - Mol Cell Res. 2022;1869:119330. doi:10.1016/j.bbamcr.2022.119330.
   PubMed Web of Science ®Google Scholar
• Wanders RJA, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem. 2006;75:295–332. doi:10.1146/annurev.biochem.74.082803.133329.
   PubMed Web of Science ®Google Scholar
• Reuber BE, Germain-Lee E, Collins CS, Morrell JC, Ameritunga R, Moser HW, Valle D, Gould SJ. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet. 1997;17: 445–8. doi:10.1038/ng1297-445.
   PubMed Web of Science ®Google Scholar
• Collins CS, Gould SJ. Identification of a common PEX1 mutation in Zellweger syndrome. Hum Mutat. 1999;14:45–53. doi:10.1002/(SICI)1098-1004(1999)14:1<45:AID-HUMU6>3.0.CO;2-J.
   PubMed Web of Science ®Google Scholar
• Walter C, Gootjes J, Mooijer PA, Portsteffen H, Klein C, Waterham HR, Barth PG, Epplen JT, Kunau W-H, Wanders RJA, et al. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Am J Hum Genet. 2001;69(1):35–48. doi:10.1086/321265.
   PubMed Web of Science ®Google Scholar
• Klouwer FCC, Berendse K, Ferdinandusse S, Wanders RJA, Engelen M, Poll-The BT. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis. 2015;10:151–151. doi:10.1186/s13023-015-0368-9.
   PubMed Web of Science ®Google Scholar
• Braverman NE, D’Agostino MD, Maclean GE. Peroxisome biogenesis disorders: biological, clinical and pathophysiological perspectives. Dev Disabil Res Rev. 2013;17(3):187–196. doi:10.1002/ddrr.1113.
   PubMedGoogle Scholar
• Braverman NE, Raymond GV, Rizzo WB, Moser AB, Wilkinson ME, Stone EM, Steinberg SJ, Wangler MF, Rush ET, Hacia JG, et al. Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol Genet Metab. 2016;117(3):313–21. doi:10.1016/j.ymgme.2015.12.009.
   PubMed Web of Science ®Google Scholar
• Stanescu B, Dralands L. Cerebro-hepato-renal (Zellweger’s) syndrome: ocular involvement. Arch Ophthalmol. 1972;87:590–2. doi:10.1001/archopht.1972.01000020592018.
   PubMedGoogle Scholar
• Hittner HM, Kretzer FL, Mehta RS. Zellweger syndrome: lenticular opacities indicating carrier status and lens abnormalities characteristic of homozygotes. Arch Ophthalmol. 1981;99:1977–82. doi:10.1001/archopht.1981.03930020853008.
   PubMedGoogle Scholar
• O’Neill DP. The eye and liver disorders. Eye. 1992;6:366–70. doi:10.1038/eye.1992.75.
   PubMed Web of Science ®Google Scholar
• Folz SJ, Trobe JD. The peroxisome and the eye. Surv Ophthalmol. 1991;35(5):353–68. doi:10.1016/0039-6257(91)90185-i.
   PubMed Web of Science ®Google Scholar
• Majewski J, Wang Z, Lopez I, Al Humaid S, Ren H, Racine J, Bazinet A, Mitchel G, Braverman N, Koenekoop RK, et al. A new ocular phenotype associated with an unexpected but known systemic disorder and mutation: novel use of genomic diagnostics and exome sequencing. J Med Genet. 2011;48(9):593–96. doi:10.1136/jmedgenet-2011-100288.
   PubMed Web of Science ®Google Scholar
• Ratbi I, Jaouad IC, Elorch H, Al-Sheqaih N, Elalloussi M, Lyahyai J, Berraho A, Newman WG, Sefiani A. Severe early onset retinitis pigmentosa in a Moroccan patient with Heimler syndrome due to novel homozygous mutation of PEX1 gene. Eur J Med Genet. 2016;59:507–11. doi:10.1016/j.ejmg.2016.09.004.
   PubMed Web of Science ®Google Scholar
• Ratbi I, Falkenberg K, Sommen M, Al-Sheqaih N, Guaoua S, Vandeweyer G, Urquhart J, Chandler K, Williams S, Roberts N, et al. Heimler syndrome is caused by hypomorphic mutations in the peroxisome-biogenesis genes PEX1 and PEX6. Am J Hum Genet. 2015;97(4):535–45. doi:10.1016/j.ajhg.2015.08.011.
   PubMed Web of Science ®Google Scholar
• Yergeau C, Coussa RG, Antaki F, Argyriou C, Koenekoop RK, Braverman NE. Zellweger spectrum disorder: ophthalmic findings from a new natural history study cohort and scoping literature review. Ophthalmology. 2023;130: 1313–26. doi:10.1016/j.ophtha.2023.07.026.
   PubMed Web of Science ®Google Scholar
• Berendse K, Engelen M, Ferdinandusse S, Majoie CBLM, Waterham HR, Vaz FM, Koelman JHTM, Barth PG, Wanders RJA, Poll‐The BT, et al. Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood. J Inherit Metab Dis. 2016;39(1):93–106. doi:10.1007/s10545-015-9880-2.
   PubMed Web of Science ®Google Scholar
• Barth PG, Schutgens RBH, Wanders RJA, Heymans HSA, Moser AE, Moser HW, Bleeker‐Wagemakers EM, Jansonius‐Schultheiss K, Derix M, Nelck GF, et al. A sibship with a mild variant of Zellweger syndrome. J Inherit Metab Dis. 1987;10(3):253–59. doi:10.1007/bf01800071.
   PubMed Web of Science ®Google Scholar
• Buckley TMW, Josan AS, Taylor LJ, Jolly JK, Cehajic-Kapetanovic J, MacLaren RE. Characterizing visual fields in RPGR related retinitis pigmentosa using octopus static-automated perimetry. Transl Vis Sci Technol. 2022;11:15. doi:10.1167/tvst.11.5.15.
   PubMed Web of Science ®Google Scholar
• Molina-Martín A, Piñero DP, Pérez-Cambrodí RJ. Normal values for microperimetry with the MAIA microperimeter: sensitivity and fixation analysis in healthy adults and children. Eur J Ophthalmol. 2017;27(5):607–13. doi:10.5301/ejo.5000930.
   PubMed Web of Science ®Google Scholar
• Talib M, Jolly JK, Boon CJF. Measuring Central Retinal Sensitivity Using Microperimetry. In: Camiel JFBoon, Jan Wijnholds, editors. Retinal gene therapy: methods and protocols. Springer New York; 2018. pp. 339–49. doi:10.1007/978-1-4939-7522-8_25.
   Google Scholar
• Bose M, Yergeau C, D’Souza Y, Cuthbertson DD, Lopez MJ, Smolen AK, Braverman NE. Characterization of severity in Zellweger spectrum disorder by clinical findings: a scoping review, meta-analysis and medical chart review. Cells. 2022;11:1891. doi:10.3390/cells11121891.
   PubMed Web of Science ®Google Scholar
• Ebberink MS, Csanyi B, Chong WK, Denis S, Sharp P, Mooijer PAW, Dekker CJM, Spooner C, Ngu LH, De Sousa C, et al. Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene. J Med Genet. 2010;47(9):608–15. doi:10.1136/jmg.2009.074302.
   PubMed Web of Science ®Google Scholar
• Lipiński P, Stawiński P, Rydzanicz M, Wypchło M, Płoski R, Stradomska TJ, Jurkiewicz E, Ferdinandusse S, Wanders RJA, Vaz FM, et al. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants. J Appl Genet. 2020;61(1):87–91. doi:10.1007/s13353-019-00523-w.
   PubMed Web of Science ®Google Scholar
• Talib M, van Schooneveld MJ, Wijnholds J, van Genderen MM, Schalij‐Delfos NE, Talsma HE, Florijn RJ, ten Brink JB, Cremers FPM, Thiadens AAHJ, et al. Defining inclusion criteria and endpoints for clinical trials: a prospective cross-sectional study in CRB1-associated retinal dystrophies. Acta Ophthalmol. 2021;99:402–14. doi:10.1111/aos.14597.
   Web of Science ®Google Scholar
• Pakzad-Vaezi KL, Maberley DA. Infantile refsum disease in a young adult: case presentation and brief review. Retin Cases Brief Rep. 2014;8:56–9. doi:10.1097/icb.0000000000000004.
   PubMedGoogle Scholar
• Pfau M, Jolly JK, Wu Z, Denniss J, Lad EM, Guymer RH, Fleckenstein M, Holz FG, Schmitz-Valckenberg S. Fundus-controlled perimetry (microperimetry): application as outcome measure in clinical trials. Prog Retin Eye Res. 2021;82:100907. doi:10.1016/j.preteyeres.2020.100907.
   PubMed Web of Science ®Google Scholar
• Hahn LC, van Schooneveld MJ, Wesseling NL, Florijn RJ, ten Brink JB, Lissenberg-Witte BI, Strubbe I, Meester-Smoor MA, Thiadens AA, Diederen RM, et al. X-Linked Retinoschisis: novel clinical observations and genetic spectrum in 340 patients. Ophthalmology. 2022;129(2):191–202. doi:10.1016/j.ophtha.2021.09.021.
   PubMed Web of Science ®Google Scholar
• Georgiou M, Finocchio L, Fujinami K, Fujinami-Yokokawa Y, Virgili G, Mahroo OA, Webster AR, Michaelides M. X-Linked retinoschisis: deep phenotyping and genetic characterization. Ophthalmology. 2022;129:542–51. doi:10.1016/j.ophtha.2021.11.019.
   PubMed Web of Science ®Google Scholar
• Miranda V, Cortez L, Rosmaninho-Salgado J, Ramos F, Paiva C. Ophthalmic manifestations of heimler syndrome in two siblings with PEX1 variants. J Pediat Ophth Strab. 2023;1–8. doi:10.3928/01913913-20230220-01.
   Web of Science ®Google Scholar
• Ventura MJ, Wheaton D, Xu M, Birch D, Bowne SJ, Sullivan LS, Daiger SP, Whitney AE, Jones RO, Moser AB, et al. Diagnosis of a mild peroxisomal phenotype with next-generation sequencing. Mol Genet Metab Rep. 2016;9:75–78.
   PubMed Web of Science ®Google Scholar
• Barillari MR, Karali M, Di Iorio V, Contaldo M, Piccolo V, Esposito M, Costa G, Argenziano G, Serpico R, Carotenuto M, et al. Mild form of Zellweger Spectrum Disorders (ZSD) due to variants in PEX1: detailed clinical investigation in a 9-years-old female. Mol Genet Metab Rep. 2020;24:100615.
   PubMed Web of Science ®Google Scholar
• Rosewich H, Ohlenbusch A, Gärtner J. Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations. J Med Genet. 2005;42:e58. doi:10.1136/jmg.2005.033324.
   PubMed Web of Science ®Google Scholar
• Preuss N, Brosius U, Biermanns M, Muntau AC, Conzelmann E, Gärtner J. PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease. Pediatr Res. 2002;51:706–14. doi:10.1203/00006450-200206000-00008.
   PubMed Web of Science ®Google Scholar
• Crane DI, Maxwell MA, Paton BC. PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders. Hum Mutat. 2005;26:167–75. doi:10.1002/humu.20211.
   PubMed Web of Science ®Google Scholar
• Argyriou C, Polosa A, Cecyre B, Hsieh M, Di Pietro E, Cui W, Bouchard JF, Lachapelle P, Braverman N. A longitudinal study of retinopathy in the PEX1-Gly844Asp mouse model for mild zellweger spectrum disorder. Exp Eye Res. 2019;186:107713. doi:10.1016/j.exer.2019.107713.
   PubMed Web of Science ®Google Scholar
• Zaki MS, Heller R, Thoenes M, Nürnberg G, Stern-Schneider G, Nürnberg P, Karnati S, Swan D, Fateen E, Nagel-Wolfrum K, et al. PEX6 is expressed in photoreceptor cilia and mutated in Deafblindness with enamel dysplasia and microcephaly. Hum Mutat. 2016;37(2):170–74. doi:10.1002/humu.22934.
   PubMed Web of Science ®Google Scholar
• Das Y, Swinkels D, Baes M. Peroxisomal disorders and their mouse models point to essential roles of peroxisomes for retinal integrity. Int J Mol Sci. 2021;22(8):4101. doi:10.3390/ijms22084101.
   PubMed Web of Science ®Google Scholar
• Hiebler S, Masuda T, Hacia JG, Moser AB, Faust PL, Liu A, Chowdhury N, Huang N, Lauer A, Bennett J, et al. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder. Mol Genet Metab. 2014;111(4):522–32. doi:10.1016/j.ymgme.2014.01.008.
   PubMed Web of Science ®Google Scholar
• Boon CJF, Jeroen Klevering B, Keunen JEE, Hoyng CB, Theelen T. Fundus autofluorescence imaging of retinal dystrophies. Vision Res. 2008;48:2569–77. doi:10.1016/j.visres.2008.01.010.
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Hosoba K, Itabashi T, Iwane AH, Akutsu SN, Ochiai H, Saito Y, Yamamoto T, Matsuura S. Insufficiency of ciliary cholesterol in hereditary zellweger syndrome. EMBO J. 2020;39:e103499. doi:10.15252/embj.2019103499.
   PubMed Web of Science ®Google Scholar